COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, MV Madhavan, D Jimenez… - JOURNAL OF THE …, 2020 - irinsubria.uninsubria.it
Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe
acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to …
acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to …
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Global COVID-19 Thrombosis … - Journal of the …, 2020 - utsouthwestern.elsevierpure.com
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
[HTML][HTML] COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, MV Madhavan, D Jimenez, T Chuich… - Journal of the American …, 2020 - Elsevier
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, M Madhavan, D Jimenez, T Chuich, I Dreyfus… - 2021 - covid19.neicon.ru
Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe
acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to …
acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to …
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, MV Madhavan, D Jimenez, T Chuich… - 2020 - wslhd.intersearch.com.au
Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe
acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to …
acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to …
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, M Madhavan, D Jimenez, T Chuich… - JOURNAL OF THE …, 2020 - boa.unimib.it
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli - 2021 - openrepository.ru
anticoagulant agent, antithrombocytic agent, antivitamin K, azithromycin, chloroquine,
heparin, hydroxychloroquine, interferon, lopinavir plus ritonavir, low molecular weight …
heparin, hydroxychloroquine, interferon, lopinavir plus ritonavir, low molecular weight …
COVID-19 and Thrombotic or Thromboembolic
B Bikdeli, MV Madhavan, D Jimenez - J Am Coll Cardiol, 2020 - suecal.com
2. Furthermore, many patients receiving antithrombotic therapy for thrombotic disease may
develop COVID-19, which can have implications for choice, dosing, and laboratory …
develop COVID-19, which can have implications for choice, dosing, and laboratory …
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
B Bikdeli, MV Madhavan, D Jimenez… - Journal of the …, 2020 - europepmc.org
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …